Microbix Biosystems Inc (MBX.TO)
0.33
0.00 (0.00%)
CAD |
TSX |
May 10, 13:14
Microbix Biosystems Free Cash Flow (Quarterly): 1.302M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.302M |
| September 30, 2023 | -1.574M |
| June 30, 2023 | 1.916M |
| March 31, 2023 | -1.607M |
| December 31, 2022 | -0.846M |
| September 30, 2022 | -1.061M |
| June 30, 2022 | 2.445M |
| March 31, 2022 | 0.4929M |
| December 31, 2021 | -0.4373M |
| September 30, 2021 | 1.493M |
| June 30, 2021 | -0.8899M |
| March 31, 2021 | 0.6631M |
| December 31, 2020 | -0.4622M |
| September 30, 2020 | -0.3606M |
| June 30, 2020 | 0.3989M |
| March 31, 2020 | -0.9505M |
| December 31, 2019 | 0.1069M |
| September 30, 2019 | 0.2659M |
| June 30, 2019 | -0.3057M |
| March 31, 2019 | -0.4287M |
| December 31, 2018 | -0.0019M |
| September 30, 2018 | 0.2726M |
| June 30, 2018 | -0.2529M |
| March 31, 2018 | 0.1548M |
| December 31, 2017 | -1.930M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.4217M |
| June 30, 2017 | 0.1461M |
| March 31, 2017 | -0.172M |
| December 31, 2016 | 0.1038M |
| September 30, 2016 | 0.10M |
| June 30, 2016 | 0.2376M |
| March 31, 2016 | -0.3569M |
| December 31, 2015 | -0.7085M |
| September 30, 2015 | -0.3595M |
| June 30, 2015 | -1.246M |
| March 31, 2015 | -1.676M |
| December 31, 2014 | -0.9651M |
| September 30, 2014 | -1.942M |
| June 30, 2014 | -1.255M |
| March 31, 2014 | -1.176M |
| December 31, 2013 | -0.1779M |
| September 30, 2013 | 0.686M |
| June 30, 2013 | 0.0576M |
| March 31, 2013 | -0.4602M |
| December 31, 2012 | -0.0835M |
| September 30, 2012 | -0.8057M |
| June 30, 2012 | -0.2966M |
| March 31, 2012 | -0.606M |
| December 31, 2011 | -0.122M |
| September 30, 2011 | -0.2279M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.607M
Minimum
Mar 2023
2.445M
Maximum
Jun 2022
0.0311M
Average
-0.3057M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0062M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0359M |
| Lobe Sciences Ltd | -0.0948M |